OBJECTIVES: To identify the prescription profile for anti-ulcerous and hypolipemic drugs during the three-year period 1994-1996 in the Jerez Primary Care district, and the differences in prescription between the reformed (Health Centres) and the unreformed networks (non-hospital clinics). DESIGN: Longitudinal, retrospective study, out of a complete sample. SETTING: Primary Care. PARTICIPANTS: Total number of general medical consultations. MEASUREMENTS AND MAIN RESULTS: The first quarter of each year was studied. Dose per 1,000 inhabitants per day (DID) was the indicator. Consumption of anti-ulcer drugs grew from 11.43 DID in 1994 to 15 in 1996 (31.23%). In the reformed network, consumption grew from 10.25 to 13.26 DID (29.37%); and in the non-reformed, from 12.56 to 16.72 DID (33.12%). Hypolipemic use went up from 8 DID in 1994 to 10.32 in 1996 (29%). CONCLUSIONS: Anti-ulcer and hypolipemic drug use increased over the study period. Both consumption and increases were lower in Health Centres. Increase in statin use led to a light decline in fibrate use in the reformed network, but not in non-hospital clinics.
OBJECTIVES: To identify the prescription profile for anti-ulcerous and hypolipemic drugs during the three-year period 1994-1996 in the Jerez Primary Care district, and the differences in prescription between the reformed (Health Centres) and the unreformed networks (non-hospital clinics). DESIGN: Longitudinal, retrospective study, out of a complete sample. SETTING: Primary Care. PARTICIPANTS: Total number of general medical consultations. MEASUREMENTS AND MAIN RESULTS: The first quarter of each year was studied. Dose per 1,000 inhabitants per day (DID) was the indicator. Consumption of anti-ulcer drugs grew from 11.43 DID in 1994 to 15 in 1996 (31.23%). In the reformed network, consumption grew from 10.25 to 13.26 DID (29.37%); and in the non-reformed, from 12.56 to 16.72 DID (33.12%). Hypolipemic use went up from 8 DID in 1994 to 10.32 in 1996 (29%). CONCLUSIONS: Anti-ulcer and hypolipemic drug use increased over the study period. Both consumption and increases were lower in Health Centres. Increase in statin use led to a light decline in fibrate use in the reformed network, but not in non-hospital clinics.
Authors: Alfonso Carvajal; Luis H Martín Arias; Eva Vega; José Antonio García Sánchez; Igor Martín Rodríguez; Pilar García Ortega; Javier García del Pozo Journal: Eur J Clin Pharmacol Date: 2004-06-23 Impact factor: 2.953